Drug-Induced Urolithiasis - 06/08/11
Doi : 10.1016/j.cvsm.2008.09.004
Carl A. Osborne, DVM, PhD ⁎ 
, Jody P. Lulich, DVM, PhD, Laurie L. Swanson, CVT, Hasan Albasan, DVM, MS, PhD
, Jody P. Lulich, DVM, PhD, Laurie L. Swanson, CVT, Hasan Albasan, DVM, MS, PhD Veterinary Clinical Sciences Department, Minnesota Urolith Center, College of Veterinary Medicine, University of Minnesota, 1352 Boyd Avenue, St. Paul, MN 55108, USA
Corresponding author.Abstract |
The prevalence of uroliths that contain drugs, their metabolites, or toxic ingredients in dogs, cats, and other animals is unknown. The authors examine specific drugs and their use in the animal population. They discuss these drugs in terms of uroliths and urolith formation in a variety of animals, making recommendations on which drugs can be safely used based on evidence from the authors’ own studies and the literature.
Le texte complet de cet article est disponible en PDF.Keywords : Drug-induced crystalluria, Drug-induced uroliths, Uroliths, Xanthine, Crystalluria, Sulfa, Fluoroquinolone
Plan
© 2008
Elsevier Inc. Tous droits réservés.
Vol 39 - N° 1
P. 55-63 - janvier 2009 Retour au numéro
Article précédent
- Changing Paradigms in the Frequency and Management of Canine Compound Uroliths
- Lisa K. Ulrich, Carl A. Osborne, Amy Cokley, Jody P. Lulich
- Quantitative Analysis of 4468 Uroliths Retrieved from Farm Animals, Exotic Species, and Wildlife Submitted to the Minnesota Urolith Center: 1981 to 2007
- Carl A. Osborne, Hasan Albasan, Jody P. Lulich, Eugene Nwaokorie, Lori A. Koehler, Lisa K. Ulrich
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?